Abstract. Previous studies have produced inconsistent results regarding the contribution of single-nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene to ovarian cancer (OC) in various ethnicities. Additionally, little has been established with regard to the role of SNPs located in the retinoid X receptor α (RXRA), vitamin D-binding protein [also know as group-specific component (GC)] and VDR genes in non-carriers of the breast cancer 1/2 early onset (BRCA1/BRCA2) gene mutations. All participating individuals in the present study were evaluated for BRCA1 mutations (5382incC, C61G and 4153delA) with HybProbe assays, and for BRCA2 mutation (5946delT) using high-resolution melting (HRM) analysis. The associations of 8 SNPs located in RXRA, GC and VDR were investigated in OC patients without the BRCA1/BRCA2 mutations (n=245) and healthy controls (n=465). Genotyping of RXRA rs10881578 and rs10776909, and GC rs1155563 and rs2298849 SNPs was conducted by HRM analysis, while RXRA rs749759, GC rs7041, VDR BsmI rs1544410 and FokI rs2228570 genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism analysis. In addition, the gene-gene interactions among all tested SNPs were studied using the epistasis option in PLINK software. The lowest P-values of the trend test were identified for VDR rs1544410 and GC rs2298849 as P trend =0.012 and P trend =0.029, respectively. It was also found that, in the dominant inheritance model, VDR BsmI contributed to an increased risk of OC [odds ratio (OR), 1.570; 95% confidence interval (CI), 1.136-2.171; P=0.006; P corr =0.048]. The gene-gene interaction analysis indicated a significant interaction between RXRA rs749759 and VDR FokI rs2228570 (OR for interaction, 1.687; χ 2 =8.278; asymptotic P-value=0.004; P corr =0.032). In conclusion, this study demonstrated that certain VDR and RXRA SNPs may be risk factors for OC in non-carriers of BRCA1/BRCA2 mutations in the Polish population.
Introduction
Ovarian cancer (OC) is a leading cause of mortality among gynecological carcinomas in Europe and the USA (1, 2) . Approximately 85% of all OC cases are sporadic, while 15% are associated with a family history of ovarian and other cancers linked to mutations in high-penetrance genes, such as BRCA1/BRCA2, mismatch repair genes or tumor protein p53 (TP53) (3, 4) . In addition to genetic factors, there are several other determinants that modulate the risk of OC development (3, 4) , including advancing age, exposure to chemicals and/or pollutants, oral contraceptive use, parity, breast-feeding period, lifestyle and diet (3, 5) . Other factors influencing the development of OC include exposure to sunlight and dietary intake of vitamin D precursors (6) . The role of vitamin D in the homeostasis of calcium and bone health is well-established (7, 8) , and an increasing number of studies have investigated the involvement of vitamin D in numerous other aspects of health, including the growth of various cancers (9) . The actions of the active form of vitamin D, 1,25-dihydroxyvitamin D3 [1, 25(OH) 2 D 3 ], in human bodies are mediated by several different proteins. These mainly include vitamin D-binding protein (VDBP), vitamin D receptor (VDR) and retinoid X receptor (RXR) (10) (11) (12) . VDBP is a 56-58 kDa plasma α-globulin encoded by the group-specific component (GC) gene (10) . This protein functions as a major blood plasma transporter protein for vitamin D and its metabolites (10) . VDR forms heterodimers with RXR and binds to DNA to initiate a series of epigenetic events leading to chromatin rebuilding and initiation of transcription (11, 12) . Evidence has indicated that a GC single-nucleotide polymorphism (SNP) is associated with blood plasma vitamin D levels (13) . Furthermore, the VDR gene also contains various SNPs, a number of which may alter 1,25(OH) 2 D 3 action (8) . It has recently been demonstrated that certain SNPs situated in the RXR-α (RXRA) gene play a role in the development and recurrence of certain cancers (14, 15) . Therefore, in the present study, 8 SNPs in the RXRA, GC and VDR genes, situated in different blocks of linkage disequilibrium (LD), were selected in order to study whether these SNPs may be genetic risk factors for OC. These SNPs were studied in a group of healthy controls and OC patients who were non-carriers of the most common mutations of the BRCA1/BRCA2 genes. (Table I) , was performed by an experienced pathologist. Patients and controls were Caucasian and from the Wielkopolska area of Poland. The controls were composed of 465 unrelated healthy female volunteers who were matched by age to the patients with cancer (Table I) . Written informed consent was provided by all individuals involved in the study. The study procedures were approved by the Ethics Committee of Poznań University of Medical Sciences (Poznań, Poland).
Materials and methods

Patients
Genotyping. Genomic DNA was obtained from peripheral blood leukocytes by salt extraction. All participating individuals were tested for the three most common BRCA1 mutations affecting the Polish population (5382incC, C61G and 4153delA) using the LightCycler 480 system (Roche Diagnostics, Mannheim, Germany) with HybProbe probes and a LightCycler DNA Master HybProbe kit (Roche, Indianapolis, IN, USA). Information on HybProbe probe sequences is available upon request. In addition, they were tested for the presence of the most common BRCA2 mutation (5946delT) using high-resolution melting (HRM) analysis (Table II) statistic. The differences in the allele and genotype frequencies between cases and controls were determined using standard χ 2 or Fisher's exact tests. The odds ratio (OR) and associated 95% confidence interval (CI) were also calculated. Data were analyzed under recessive and dominant inheritance models. For the additive inheritance model, SNPs were tested for association with OC using the Cochran-Armitage trend test. To adjust for the multiple testing, a Bonferroni correction HRM analysis RFLP analysis ---------------------------------------------------------------------------------------------------------------------- and VDR SNPs did not indicate any contribution of SNP combinations to the risk of OC (Table IV) . In OC patients, the lowest global P-value, P=0.025, was observed for haplotypes composed of the VDR rs1544410 and rs2228570 SNPs (Table V) . However, these results did not reach significance when permutations were used to generate empirical P-values. The empirical 5% quantile of the best P-value following 1,000 permutations was 0.01066 for RXRA, 0.01146 for GC and 0.01984 for VDR. (Table V) . However, these P-values did not remain statistically significant after Bonferroni correction.
Analysis of gene-gene interactions
Discussion
Adequate 1,25(OH) 2 D 3 levels seem to be involved in the prevention of many diseases, including cardiovascular, musculoskeletal, autoimmune and infectious disorders, diabetes mellitus, infertility and others (17) . The particularly significant protective role of vitamin D has been demonstrated in the context of the development and progression of various malignancies (18) . Inadequate plasma levels of vitamin D have been associated with poor prognosis or development of head and neck cancers, thyroid, lung, liver, breast, gastric and colon cancers (19-25) . Table V . Results of gene-gene interaction analysis. Reduced vitamin D levels have also been observed in patients with OC compared with general population, and low vitamin D levels have been associated with an increased risk of developing certain histological OC subtypes, such as borderline and mucinous (26, 27) . Recently, Walentowicz-Sadlecka et al (28) reported that low levels of 25(OH)D 3 , a pre-hormonal form of vitamin D, are accompanied by a reduced survival rate in patients with OC.
The antitumor activity of 1,25(OH) 2 D 3 can be mediated by microRNA specific for the telomerase transcript in OC and in other human cancer types (29) . It has been demonstrated that 1,25(OH) 2 D 3 also inhibits proliferation of adrenocortical and pancreatic cancer cells and suppresses hepatocellular carcinoma development by reducing inflammatory cytokine production in vivo (30) (31) (32) . In addition, vitamin D inhibits motility, invasion and metastasis of squamous cell carcinoma and suppresses breast and prostate cancer progression in murine models (33, 34) . Furthermore, the vitamin D analog EB1089 was found to trigger apoptosis of gastric cancer cells, and in preclinical studies exerted an anti-proliferative effect on human OC xenografts in murine models (35, 36) .
VDRs have been identified in various types of malignant cells (37) . This implies that the anticancer action of 1,25(OH) 2 D 3 may be mediated by the levels of VDR, and also by VDBP and RXRA levels, which further suggests that SNPs situated in genes encoding these proteins may contribute to OC development.
In the present study, a significant contribution of the VDR BsmI SNP to OC was observed in the Polish population. This result confirmed our previous studies, which demonstrated a moderate association of the BsmI VDR B gene variant with OC (38) . The meta-analysis by Qin et al (39) implicated the BsmI SNP as a moderate risk factor for OC in the European population. In contrast to these findings, there was no association of the BsmI polymorphism with OC in a number of other studies, which included a Caucasian population and cohorts from Massachusetts and New Hampshire in the USA (40, 41) . Three meta-analyses also did not confirm BsmI SNP as a risk factor of OC in Caucasian, North American, Asian and overall populations (42) (43) (44) .
In the present study, no significant difference was identified in the prevalence of the FokI SNP between OC patients and controls. These observations are in agreement with those of Clendenen et al (40) , who did not observe the FokI SNP to be a risk factor for OC in Caucasian women. By contrast, other studies identified the FokI polymorphism as a risk factor for OC in Massachusetts and New Hampshire, Indian, Caucasian, Japanese and overall populations (41) (42) (43) (45) (46) (47) (48) .
The distinct influence of the BsmI and FokI SNPs on OC risk in various ethnicities may result from exposure of the studied groups to various environmental factors, the size of these groups and their genetic background. The possible role of BsmI and FokI polymorphisms on the action of VDR have been demonstrated elsewhere (8, (49) (50) (51) . The BsmI SNP may alter the length of the polyadenylate sequence within the 3'-untranslated region of the VDR gene (8) . Furthermore, Luo et al (49) demonstrated that the BsmI SNP was responsible for the significantly lowered VDR mRNA levels in patients bearing the A (B) allele as compared to bearers of the GG (bb) genotype. The FokI polymorphism results in the creation of two protein variants; longer VDR, encoded by the changed allele form (ATG) (f), has an additional three amino acids and is 1.7 times less efficient than the shorter, common allele form (ACG) (F) (50 (13) demonstrated high frequency of VDR f allele associated with a downregulation of the Th1 immune response.
In the current study, no associations were observed between OC and the SNPs GC rs1155563 and rs7041, and RXRA rs10881578, rs10776909 and rs749759. To date, certain polymorphisms situated in GC have been reported to be associated with vitamin D metabolite levels in blood plasma (13, 52) . The GC rs7041 SNP was associated with high concentrations of VDBP in blood plasma and a high binding affinity to 25(OH)D 3 in a Canadian cohort (13) . In addition, the GC (436K) alleles (rs4588) (Fig. 1B) were associated with lower 25(OH)D 3 concentrations in young Canadian adults of East Asian and European ancestry (52) .
However, in the present study, a significant interaction was identified between the RXRA rs749759 and FokI rs2228570 SNPs. Previous studies have proposed that RXRA rs7861779 and rs12004589 SNPs may be used as markers for colorectal cancer (53) . Haplotype CGGGCA (rs1805352, rs3132297, rs3132296, rs3118529, rs3118536 and rs7861779) within linkage blocks of RXRA are associated with a reduced risk of metachronous neoplasia in the proximal colon (5). The RXRA haplotype, situated 3' of the coding sequence (rs748964 and rs3118523) increased the risk of renal carcinoma among carriers with the (CG) haplotype compared to the (GA) common haplotype (54) . The RXRA SNPs (rs10881583, rs881658, rs11185659, rs881657 and rs7864987) were linked to poor disease-free survival in patients with breast cancer (15) . Furthermore, head and neck squamous cell carcinoma patients possessing the RXRA SNP rs3118570 exhibited an increased risk of developing a second primary tumor or recurrence (55) .
In conclusion, the current study confirmed that the VDR BsmI SNP is risk factor for OC in non-carriers of the BRCA1/BRCA2 mutations in the Polish population. Furthermore, a significant interaction between the RXRA rs749759 and VDR FokI rs2228570 SNPs in these studied groups was identified. However, the results of this study must be verified other independent cohorts.
